Eidarus Salah
12 Mansfield Road
Oxford, ENG OX13TA, United Kingdom
Oxford, ENG OX13TA, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Cephalosporins are potent SARS-CoV-2 main protease inhibitors.
Journal: European journal of medicinal chemistry
Published: March 30, 2026
Substrate-Selective Inhibition of the SARS-CoV-2 Papain-Like Protease: Inhibition of Hydrolysis of Human Over Viral Substrates.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: January 15, 2026
C6-Alkoxy substituted penicillins are potent non-covalently binding inhibitors of the SARS-CoV-2 main protease.
Journal: RSC medicinal chemistry
Published: September 07, 2025
Profiling Inhibitor Scaffolds for the Cancer Target Jumonji-C Domain-Containing Protein 6.
Journal: ChemMedChem
Published: August 07, 2025
Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase.
Journal: Journal of medicinal chemistry
Published: April 23, 2025
Investigating the N-terminal linker histone H1 subtypes as substrates for JmjC lysine demethylases.
Journal: RSC chemical biology
Published: April 08, 2025
Evidence human FTO catalyses hydroxylation of N6-methyladenosine without direct formation of a demethylated product contrasting with ALKBH5/2/3 and bacterial AlkB.
Journal: Nucleic acids research
Published: March 17, 2025
RaPID discovery of cell-permeable helical peptide inhibitors con-taining cyclic β-amino acids against SARS-CoV-2 main protease.
Journal: RSC chemical biology
Published: February 02, 2025
Biochemical investigations using mass spectrometry to monitor JMJD6-catalysed hydroxylation of multi-lysine containing bromodomain-derived substrates.
Journal: RSC chemical biology
Published: December 15, 2024
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies.
Journal: European journal of medicinal chemistry
Published: December 12, 2024
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9.
Journal: Nature chemistry
Published: December 02, 2024
Last Updated: 09/26/2026